Wencheng Zhang

机构：Tianjin Medical University Cancer Institute and Hospital, Shanghai East Hospital, Shanghai Cell Therapy Research Institute, Qilu Hospital of Shandong University, Tianjin Medical University · ORCID：0000-0003-3730-5361

发表论文 258 篇 · 总被引 3498 次 · h-index 33

代表论文

• Voxel-level radiomics and deep learning for predicting pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant immunotherapy and chemotherapy (2025 · Journal for ImmunoTherapy of Cancer · 被引 44)
• Preliminary results from the multicenter, randomized phase III trial (SCIENCE): Comparing chemotherapy plus sintilimab and chemoradiotherapy plus sintilimab versus chemoradiotherapy for neoadjuvant treatment in resectable locally advanced esophageal squamous cell carcinoma. (2025 · Journal of Clinical Oncology · 被引 10)
• Tirzepatide modulates gut microbiota homeostasis to protect against diabetic kidney disease (2025 · Frontiers in Molecular Biosciences · 被引 6)
• Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial (2025 · BMC Cancer · 被引 6)
• Targeting JAML promotes normalization of tumour blood vessels to antagonize tumour progression via FAK/SRC and VEGF/VEGFR2 signalling pathways (2025 · Life Sciences · 被引 6)
• Prognostic Impact of Sarcopenia and Surgical Timing in Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoradiotherapy: TIMES Study (2025 · Annals of Surgical Oncology · 被引 6)